Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy

Publisher： Karger

E-ISSN： 1421-9794|62|4|246-255

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.4, 2017-05, pp. : 246-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 387-394

Karger

Access to resources Recommend Favorite

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations

By Pistelli Mirco   Caramanti Miriam   Biscotti Tommasina   Santinelli Alfredo   Pagliacci Alessandra   De Lisa Mariagrazia   Ballatore Zelmira   Ridolfi Francesca   Maccaroni Elena   Bracci Raffaella   Berardi Rossana   Battelli Nicola   Cascinu Stefano  

Cancers, Vol. 6, Iss. 3, 2014-06 ,pp. : 1351-1362

MDPI

Access to resources Recommend Favorite

Cisplatin plus Gemcitabine Chemotherapy in Taxane/Anthracycline-Resistant Metastatic Breast Cancer

By  

Chemotherapy, Vol. 55, Iss. 3, 2009-04 ,pp. : 155-160

Karger

Access to resources Recommend Favorite

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

By Botti Gerardo   Collina Francesca   Scognamiglio Giosuè   Rao Federica   Peluso Valentina   De Cecio Rossella   Piezzo Michela   Landi Gabriella   De Laurentiis Michelino   Cantile Monica   Di Bonito Maurizio  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 459-459

MDPI

Access to resources Recommend Favorite

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

By Charehbili Ayoub   Fontein Duveken B. Y.   Kroep Judith R.   Liefers Gerrit-Jan   Nortier Johannes W. R.   van de Velde Cornelis J. H.  

Journal of Clinical Medicine, Vol. 2, Iss. 4, 2013-10 ,pp. : 188-200

MDPI

Access to resources Recommend Favorite